FOXA1 (Forkhead box protein A1), in particular, is frequently mutated, occurring in up to 9% and 13% of cases of primary prostate cancer and metastatic castration-resistant prostate cancer (mCRPC), respectively [3,9]. Here, FOXA1 is linked to prostate carcinoma.